Future large-scale epidemiological studies examining the distribution and clinical outcomes of specific VDR gene polymorphisms in different NAFLD phenotypes will provide useful evidence to the research field of pharmacogenomics and personalized medicine. Here, VDR is linked to metabolic dysfunction-associated steatotic liver disease.